BioCentury | Jun 28, 2018
Distillery Techniques

Disease models

...an oral quinazoline-based pan-HER inhibitor, in Phase II testing for various cancers. Hanmi, Spectrum and National OncoVenture...
Items per page:
1 - 1 of 1
BioCentury | Jun 28, 2018
Distillery Techniques

Disease models

...an oral quinazoline-based pan-HER inhibitor, in Phase II testing for various cancers. Hanmi, Spectrum and National OncoVenture...
Items per page:
1 - 1 of 1